Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and older. 2. Patients newly diagnosed with all stages and types of cancer, especially solid tumors, and receiving chemotherapy as a first-line treatment. 3. Patients at intermediate or high risk for VTE. 4. Patients willing to give informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to anticoagulant therapy. 2. Patients unable to engage in physical activity due to advanced disease. 3. Patients with all types of haematological cancer 4. Patients who are planned for adjuvant chemotherapy or receive another type of treatment between chemotherapy cycles, or discontinuation or non-completion of chemotherapy cycles, or who develop VTE or undergo surgery during the research study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the research study is to decrease the occurrence of VTE which includes Deep Vein Thrombosis and Pulmonary Embolism for a group receiving intervention, along with enhanced understanding and adherenceTimepoint: The outcomes will be measured at baseline during preintervention, three months, six months, and one year during postintervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Alternative outcomes might involve the count of complications related to venous thromboembolism, the duration of hospital admission, mortality associated with it, the general satisfaction of patients with the nursing care providedTimepoint: It will be measured at baseline, three months, six months, one year | — |
Countries
India
Contacts
Sikkim Manipal College of Nursing